Pilot Study of Second-Generation DNA Methylation Epigenetic Markers in Relation to Cognitive and Neuropsychiatric Symptoms in Older Adults
Journal of Alzheimer’s Disease · 2023
DOI: 10.3233/jad-230093 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Alzheimer’s Disease, 2023. Verfasst von Chirag M Vyas und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Aging, DNA Methylation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NHLBI NIH HHS.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Associations between epigenetic aging with cognitive aging and neuropsychiatric measures are not well-understood.
Objective
1) To assess cross-sectional correlations between second-generation DNA methylation (DNAm)-based clocks of healthspan and lifespan (i.e., GrimAge, PhenoAge, and DNAm-based estimator of telomere length [DNAmTL]) and cognitive and neuropsychiatric measures; 2) To examine longitudinal associations between change in DNAm markers and change in cognition over 2 years.
Methods
Participants were members of VITAL-DEP (VITamin D and OmegA-3 TriaL- Depression Endpoint Prevention) study. From previously ascertained cognitive groups (i.e., cognitively normal and mild cognitive impairment), we randomly selected 45 participants, aged≥60 years, who completed in-person neuropsychiatric assessments at baseline and 2 years. The primary outcome was global cognitive score (averaging z-scores of 9 tests). Neuropsychiatric Inventory severity scores were mapped from neuropsychiatric symptoms (NPS) from psychological scales and structured diagnostic interviews. DNAm was assayed using Illumina MethylationEPIC 850K BeadChip at baseline and 2 years. We calculated baseline partial Spearman correlations between DNAm markers and cognitive and NPS measures. We constructed multivariable linear regression models to examine longitudinal relations between DNAm markers and cognition.
Results
At baseline, we observed a suggestive negative correlation between GrimAge clock markers and global cognition but no signal between DNAm markers and NPS measures. Over 2 years: each 1-year increase in DNAmGrimAge was significantly associated with faster declines in global cognition; each 100-base pair increase in DNAmTL was significantly associated with better global cognition.
Conclusion
We found preliminary evidence of cross-sectional and longitudinal associations between DNAm markers and global cognition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
- Department of Molecular Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
- Division of Geriatric Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
- Department of Psychiatry, UPMC and University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- Department of Psychiatry, VA Boston Healthcare System and Harvard Medical School, Boston, MA, USA.
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- NIAMS NIH HHS
- NIMH NIH HHS
- NCATS NIH HHS
- NCCIH NIH HHS
- NIA NIH HHS
Zitieren
APA
Vyas, C. M., Sadreyev, R. I., Gatchel, J. R., Kang, J. H., Reynolds, C. F., Mischoulon, D., Chang, G., Hazra, A., Manson, J. E., Blacker, D., De Vivo, I., & Okereke, O. I. (2023). Pilot Study of Second-Generation DNA Methylation Epigenetic Markers in Relation to Cognitive and Neuropsychiatric Symptoms in Older Adults. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-230093
Vancouver
Vyas CM, Sadreyev RI, Gatchel JR, Kang JH, Reynolds CF, Mischoulon D, et al. Pilot Study of Second-Generation DNA Methylation Epigenetic Markers in Relation to Cognitive and Neuropsychiatric Symptoms in Older Adults. Journal of Alzheimer’s Disease. 2023. doi:10.3233/jad-230093
BibTeX
@article{Vyas2023,
author = {Vyas, Chirag M and Sadreyev, Ruslan I and Gatchel, Jennifer R and Kang, Jae H and Reynolds, Charles F and Mischoulon, David and Chang, Grace and Hazra, Aditi and Manson, JoAnn E and Blacker, Deborah and De Vivo, Immaculata and Okereke, Olivia I},
title = {Pilot Study of Second-Generation DNA Methylation Epigenetic Markers in Relation to Cognitive and Neuropsychiatric Symptoms in Older Adults},
journal = {Journal of Alzheimer’s Disease},
year = {2023},
doi = {10.3233/jad-230093}
}
EUVIMED